Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Director departure
Quarterly results
CC transcript
Asset disposition
Inv. presentation

HARVARD BIOSCIENCE INC (HBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/03/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Vice President, Finance"
02/26/2020 8-K/A Quarterly results
03/18/2019 8-K/A Quarterly results
Docs: "Harvard Bioscience Reports Strong Fourth Quarter and Year-End 2018 Results, and Issues 2019 Financial Guidance -Reports record Fourth Quarter GAAP and adjusted non-GAAP revenue of $33.9 million, a year-over-year increase of 56% and 24%, respectively- HOLLISTON, MA – February 28, 2019 -- Harvard Bioscience, Inc. , a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported its financial results for the fourth quarter and full year ended December 31, 2018. “I am extremely proud of our team’ s fourth quarter execution. In addition to strong growth in adjusted gross profit, adjusted operating income, and adjusted earnings per share, we also reported record quarterly revenue of $33.9 million”, said Jeffrey Duchemin, President and CEO of Harvard ..."
04/17/2018 8-K/A Financial Statements and Exhibits
Docs: "Consent of Independent Auditor RSM US LLP",
"Audited Consolidated Financial Statements of Data Sciences International, Inc. for the years ended June 30, 2017 and June 30, 2016, and the notes related thereto, and interim Unaudited Consolidated Financial Statements of Data Sciences International, Inc. for the six month period ended December 31, 2017 and the six month period ended December 31, 2016, and the notes related thereto",
"Unaudited Pro Forma Condensed Combined Financial Information of Harvard Bioscience, Inc. for the year ended December 31, 2017, and the notes related thereto"
10/30/2017 8-K/A Quarterly results
11/07/2013 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Harvard Bioscience, Inc. Unaudited Pro Forma Condensed Consolidated Financial Statements",
"Harvard Bioscience, Inc. Unaudited Pro Forma Condensed Consolidated Financial Statements"
11/19/2009 8-K/A Form 8-K/A - Current report [Amend]
10/06/2008 8-K/A Form 8-K/A - Current report [Amend]
12/06/2007 8-K/A Form 8-K/A - Current report [Amend]
05/17/2004 8-K/A Form 8-K/A - Current report [Amend]
05/27/2003 8-K/A Form 8-K/A - Current report [Amend]
08/14/2001 8-K/A Form 8-K/A - Current report [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy